PJP.US Invesco Dynamic Pharmaceuticals ETF
- Total assets
- 604M
- Expense ratio
- 0.57%
- Dividend yield
- 0.87%
- 1-year return
- +33.92%
- Holdings
- 28
- Since
- 2005
Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.
What does PJP.US invest in?
- Mostly US stocks (104.2%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (100.0%)
- Top 3 holdings: 18.5% of the fund
Asset allocation
- US stocks 104.2%
- Cash 0.1%
Top holdings
- Eli Lilly and Company 6.35%
- Gilead Sciences Inc 6.14%
- AbbVie Inc 5.95%
- Amgen Inc 5.73%
- Johnson & Johnson 5.65%
Invesco Dynamic Pharmaceuticals ETF performance
Sharpe ratio 1.40- This year
- +26.26%
- 1 year
- +33.92%
- 3 years
- +24.22%
- 5 years
- +10.77%
Volatility 14.3% over 1 year and 13.5% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
PJP.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Invesco Dynamic Pharmaceuticals ETF
The underlying index, which is composed of common stocks of 30 U.S. pharmaceutical companies. Under normal circumstances, at least 80% of the value of its net assets, plus the amount of any borrowings for investment purposes, in securities of companies engaged in the pharmaceuticals industry, and in derivatives and other investments that have economic characteristics similar to securities of companies engaged in the pharmaceuticals industry (the "80% investment policy"). The…
Full fund profileInvesco Dynamic Pharmaceuticals ETF top holdings
52.8% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 6.35% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 6.14% |
| AbbVie Inc ABBV.US | Healthcare | United States | 5.95% |
| Amgen Inc AMGN.US | Healthcare | United States | 5.73% |
| Johnson & Johnson JNJ.US | Healthcare | United States | 5.65% |
| Pfizer Inc PFE.US | Healthcare | United States | 5.22% |
| Merck & Company Inc MRK.US | Healthcare | United States | 5.13% |
| Abbott Laboratories ABT.US | Healthcare | United States | 4.98% |
| Viatris Inc VTRS.US | Healthcare | United States | 3.86% |
| Amneal Pharmaceuticals, Inc. Class A Common Stock AMRX.US | Healthcare | United States | 3.77% |
The 10 largest of 28 holdings.
PJP.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
PJP.US regional exposure
- North America100.0%
Share of the stocks in the fund.
Company size
Average market cap 43.7B- Mega cap5.9%
- Big cap43.6%
- Medium cap10.3%
- Small cap16.3%
- Micro cap22.6%
Invesco Dynamic Pharmaceuticals ETF fund profile
- Fund name
- Invesco Dynamic Pharmaceuticals ETF
- Ticker
- PJP.US
- Exchange
- USA Stocks
- Issuer
- Invesco
- Index tracked
- -
- Category
- Healthcare Equity
- Domicile
- United States
- Inception date
- Jun 23, 2005
- Trading currency
- USD
- Expense ratio
- 0.57%
- Annual turnover
- 0.4%
About Invesco Dynamic Pharmaceuticals ETF
The underlying index, which is composed of common stocks of 30 U.S. pharmaceutical companies. Under normal circumstances, at least 80% of the value of its net assets, plus the amount of any borrowings for investment purposes, in securities of companies engaged in the pharmaceuticals industry, and in derivatives and other investments that have economic characteristics similar to securities of companies engaged in the pharmaceuticals industry (the "80% investment policy"). The fund is non-diversified.